Multaq FDA Approval History
FDA Approved: Yes (First approved July 1, 2009)
Brand name: Multaq
Generic name: dronedarone
Dosage form: Tablets
Treatment for: Atrial Fibrillation, Atrial Flutter
Multaq (dronedarone) is antiarrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter.
Development timeline for Multaq
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.